Acral lentiginous melanoma

Acral lentiginous melanoma
Acral lentiginous melanoma on the sole of foot
SpecialtyDermatology
SymptomsAreas of dark pigmentation[1]
ComplicationsUlceration, spread[1]
Usual onset60 years to 70 years[2]
CausesMalignant melanocytes[3][4]
Risk factorsDark skin[1]
Diagnostic methodBiopsy[5]
TreatmentBiologic immunotherapy agents[6]
FrequencyMales = females[1]

Acral lentiginous melanoma is a type of skin cancer.[1] It typically begins as a uniform brownish mark before becoming darker and wider with a blurred irregular edge, most frequently seen in the foot of a person with darker skin.[1] It may become bumpy and ulcerate.[1] Just under the nail it typically appears as dark longitudinal streaks.[2] It may spread.[2]

Acral lentiginous melanoma arises from pigment cells.[7] It occurs on non-hair-bearing surfaces of the body, which have not necessarily been exposed to sunlight. It is observed on the palms, soles, under the nails and in the mouth.[8] The average age at diagnosis is between 60 years and 70 years.[2]

Acral lentiginous melanoma is the most common form of melanoma amongst Asian and sub-Saharan African ethnic groups.[9] 60% occur in the nails, palms and soles.[1] Males and females are affected equally.[1]

Signs and symptoms

It typically begins as a uniform brownish mark before becoming darker and wider with a blurred irregular edge, most frequently seen in the foot of a person with darker skin.[1] It may become bumpy and ulcerate.[1] Just under the nails it may appear as dark longitudinal streaks, typically involving the proximal nail fold.[1][2]

Warning signs are new areas of pigmentation, or existing pigmentation that shows change. If caught early, acral lentiginous melanoma has a similar cure rate as the other types of superficial spreading melanoma.[10]

Skin

Nails

Acral lentiginous melanoma may present as a dark mark under a nail, or a black mark in the nail fold at the end of a dark streak.[1] There may be Hutchinson's sign.[1]

Causes

Acral lentiginous melanoma is a result of malignant melanocytes at the membrane of the skin (outer layers).[3][4] The pathogenesis of acral lentiginous melanoma remains unknown at this time.[11]

Diagnosis

Although the ideal method of diagnosis of melanoma is complete excisional biopsy,[12] alternatives may be required according to the location of the melanoma. Dermatoscopy of acral pigmented lesions is very difficult but can be accomplished with diligent focus. Initial confirmation of the suspicion can be done with a small wedge biopsy or small punch biopsy.[5] Thin deep wedge biopsies can heal very well on acral skin, and small punch biopsies can give enough clue to the malignant nature of the lesion. Once this confirmatory biopsy is done, a second complete excisional skin biopsy can be performed with a narrow surgical margin (1 mm). This second biopsy will determine the depth and invasiveness of the melanoma,[13] and will help to define what the final treatment will be. If the melanoma involves the nail fold and the nail bed, complete excision of the nail unit might be required. Final treatment might require wider excision (margins of 0.5 cm or more), digital amputation, lymphangiogram with lymph node dissection, or chemotherapy.[14]

Dermoscopy

Histology

The main characteristic of acral lentiginous melanoma is continuous proliferation of atypical melanocytes at the dermoepidermal junction.[15] Other histological signs of acral lentiginous melanoma include dermal invasion and desmoplasia.[16]

According to Scolyer et al.,[17] ALM "is usually characterized in its earliest recognisable form as single atypical melanocytes scattered along the junctional epidermal layer".


Treatment

Therapies for metastatic melanoma include the biologic immunotherapy agents ipilimumab, pembrolizumab, and nivolumab; BRAF inhibitors, such as vemurafenib and dabrafenib; and a MEK inhibitor trametinib.[6]

Prognosis

It has been demonstrated that acral lentiginous melanoma has a poorer prognosis compared to that of cutaneous malignant melanoma (CMM).[18]

Society

Jamaican musician Bob Marley died of the condition in 1981, aged 36.[19]

See also

References

  1. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 James, William D.; Elston, Dirk; Treat, James R.; Rosenbach, Misha A.; Neuhaus, Isaac (2020). "30. Melanocytic nevi and neoplasms". Andrews' Diseases of the Skin: Clinical Dermatology (13th ed.). Edinburgh: Elsevier. pp. 696–697. ISBN 978-0-323-54753-6. Archived from the original on 2023-06-30. Retrieved 2023-06-02.
  2. 1 2 3 4 5 Hall, Kelly H.; Rapini, Ronald P. (2024). "Acral Lentiginous Melanoma". StatPearls. StatPearls Publishing. PMID 32644539. Archived from the original on 2024-04-18. Retrieved 2024-05-10.
  3. 1 2 Brown, Kimberly M.; Chao, Celia (2014). Melanoma. Elsevier Health Sciences. ISBN 9780323326834. Archived from the original on 2021-08-27. Retrieved 2020-12-06.
  4. 1 2 Piliang, Melissa Peck (June 2011). "Acral Lentiginous Melanoma". Clinics in Laboratory Medicine. 31 (2): 281–288. doi:10.1016/j.cll.2011.03.005. PMID 21549241.  – via ScienceDirect (Subscription may be required or content may be available in libraries.)</
  5. 1 2 ChB, David E. Elder MB; PhD, Sook Jung Yun MD (2014-11-10). Superficial Melanocytic Pathology. Demos Medical Publishing. ISBN 9781620700235. Archived from the original on 2021-08-27. Retrieved 2020-12-06.
  6. 1 2 Maverakis E, Cornelius LA, Bowen GM, Phan T, Patel FB, Fitzmaurice S, He Y, Burrall B, Duong C, Kloxin AM, Sultani H, Wilken R, Martinez SR, Patel F (2015). "Metastatic melanoma - a review of current and future treatment options". Acta Derm Venereol. 95 (5): 516–524. doi:10.2340/00015555-2035. PMID 25520039. Archived from the original on 2018-07-19. Retrieved 2018-11-04.
  7. ↑ Phan, A.; Touzet, S.; Dalle, S.; Ronger‐Savlé, S.; Balme, B.; Thomas, L. (2007). "Acral lentiginous melanoma: histopathological prognostic features of 121 cases". British Journal of Dermatology. 157 (2): 311–318. doi:10.1111/j.1365-2133.2007.08031.x. ISSN 1365-2133. PMID 17596173.
  8. ↑ LeBoit, Philip E. (2006). Pathology and Genetics of Skin Tumours. IARC. ISBN 9789283224143. Archived from the original on 2021-08-27. Retrieved 2020-12-06.
  9. ↑ Farage, Miranda A. (2010-01-22). Textbook of Aging Skin. Springer Science & Business Media. ISBN 9783540896555. Archived from the original on 2021-08-27. Retrieved 2020-12-06.
  10. ↑ Hearing, Vincent J.; Leong, Stanley P. L. (2007-11-05). From Melanocytes to Melanoma: The Progression to Malignancy. Springer Science & Business Media. ISBN 9781592599943. Archived from the original on 2021-08-27. Retrieved 2020-12-06.
  11. ↑ ChB, David E. Elder, MB; PhD, Sook Jung Yun, MD (2014-11-10). Superficial Melanocytic Pathology. Demos Medical Publishing. p. 119. ISBN 9781617051869. Archived from the original on 2021-08-27. Retrieved 11 October 2016.
  12. ↑ Shea, Christopher R.; Reed, Jon A.; Prieto, Victor G. (2014-11-03). Pathology of Challenging Melanocytic Neoplasms: Diagnosis and Management. Springer. ISBN 9781493914449. Archived from the original on 2021-08-27. Retrieved 2020-12-06.
  13. ↑ Barnhill, Raymond L.; Piepkorn, Michael; Busam, Klaus J. (2014-02-18). Pathology of Melanocytic Nevi and Melanoma. Springer Science & Business Media. ISBN 9783642383854. Archived from the original on 2021-08-27. Retrieved 2020-12-06.
  14. ↑ Clarke, Loren E.; Clarke, Jennie T.; Helm, Klaus F. (2014-03-01). Color Atlas of Differential Diagnosis in Dermatopathology. JP Medical Ltd. ISBN 9789350908457. Archived from the original on 2021-08-31. Retrieved 2020-12-06.
  15. ↑ Piliang, Melissa Peck (2009). "Acral Lentiginous Melanoma". Surgical Pathology Clinics. 2 (3): 535–541. doi:10.1016/j.path.2009.08.005. ISSN 1875-9181. PMID 26838538.
  16. ↑ Mooi, Walter; Krausz, Thomas (2007-09-28). Pathology of Melanocytic Disorders 2ed. CRC Press. ISBN 9781444113808. Archived from the original on 2021-08-27. Retrieved 2020-12-06.
  17. ↑ "FEBS Press". doi:10.1002/(ISSN)1878-0261. Archived from the original on 2021-08-31. Retrieved 2015-05-23.
  18. ↑ Bradford, Porcia T.; Goldstein, Alisa M.; McMaster, Mary L.; Tucker, Margaret A. (2009). "Acral Lentiginous Melanoma: Incidence and Survival Patterns in the United States, 1986-2005". Archives of Dermatology. 145 (4): 427–434. doi:10.1001/archdermatol.2008.609. ISSN 0003-987X. PMC 2735055. PMID 19380664.
  19. ↑ "Bob Marley Shouldn't Have Died from Melanoma". Skin Cancer Foundation. 2016-02-06. Archived from the original on 2019-07-27. Retrieved 2016-10-11.
Classification
This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.